Download PDF

Other users also viewed these articles

Effectiveness of intravenous tocilizumab in routine clinical practice in a cohort of Costa Rican patients with rheumatoid arthritis Mauricio Cordero-Alfaro; Carlos León-Céspedes; Allan Ramos-Esquivel;
Reumatol Clin. 2021;17:329-34
Right ventriculoarterial coupling as a marker of subclinical myocardial damage in rheumatoid arthritis Tomás Miranda-Aquino; Diego Alejandro Ramos-Aguas; Silvia Esmeralda Pérez-Topete; María del Socorro Cepeda-Rocha; Xochitl Citlalli Gómez-Gómez; Daniel Ochoa-Castillo; Sergio Cerpa-Cruz; Verónica González-Díaz; Christian González-Padilla; Jorge Eduardo Hernández-del Río;
10.1016/j.reumae.2025.501841
Safety of biologic and synthetic targeted therapies in patients with immune-mediated diseases: data from the BIOBADAGUAY registry Paloma de Abreu; Sonia Cabrera; Darwin Cordovilla; Lourdes Román; Cristina Brunengo; Patricia Melgarejo; Macarena Soto; Vannia Valinotti; Angelica Amarilla; Belem Acevedo; Alexis Pineda; Evelyn Leiva; Paola Pusineri; Sandra Consani; Mariela Zarza; Clyde Parodi; Zoilo Morel; Roger Rolón; Paola Jara; Raquel Aranda; Laura Martínez; Gabriela Ávila;
Reumatol Clin. 2025;21: